Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Dear Doctor Letter (Rote-Hand-Brief) on Fingolimod (Gilenya®): Risks related to the effects on the immune system
2016.01.20
Active substance: fingolimod
The company Novartis Pharma GmbH is circulating information on recent product information changes in relation to immunosuppressive effects.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN